ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.67	59.41	23.38	66.84	226.01	78.45
Short-Term Investments	237.47	196.55	184.8	139.43	10.97	215.15
Cash & Short-Term Investments	287.14	255.96	208.19	206.27	236.98	293.6
Cash Growth	5.42%	22.95%	0.93%	-12.96%	-19.29%	229.30%
Prepaid Expenses	8.45	6.29	4.41	4.18	3.54	3.1
Total Current Assets	295.59	262.25	212.6	210.46	240.52	296.7
Property, Plant & Equipment	2.56	11.3	12.01	14.24	14.21	1.98
Long-Term Investments	125.91	-	26.85	21.95	43.39	-
Other Long-Term Assets	7.13	0.59	0.55	0.53	0.52	0.32
Total Assets	431.19	274.14	252.01	247.18	298.64	299
Accounts Payable	2.9	1.55	0.94	1.32	1.89	0.76
Accrued Expenses	13.98	20.12	16.76	11.41	11.34	7.7
Current Portion of Leases	3.3	3.18	2.75	2.66	1.93	-
Other Current Liabilities	-	-	-	-	-	0.55
Total Current Liabilities	20.18	24.85	20.46	15.39	15.15	9
Long-Term Leases	4.09	6.17	7.46	9.44	10.52	-
Other Long-Term Liabilities	-	-	-	-	-	0.22
Total Liabilities	24.27	31.02	27.92	24.83	25.67	9.22
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,068	805.51	658.75	557.87	518.18	456.2
Retained Earnings	-661.74	-562.77	-434.93	-334.23	-245.11	-166.39
Comprehensive Income & Other	0.62	0.38	0.26	-1.29	-0.1	-0.03
Total Common Equity	406.92	243.12	224.09	222.35	272.98	289.78
Shareholders' Equity	406.92	243.12	224.09	222.35	272.98	289.78
Total Liabilities & Equity	431.19	274.14	252.01	247.18	298.64	299
Total Debt	7.4	9.36	10.21	12.1	12.44	-
Net Cash (Debt)	279.75	246.6	197.97	194.17	224.54	293.6
Net Cash Growth	6.60%	24.56%	1.96%	-13.52%	-23.52%	229.30%
Net Cash Per Share	3.51	3.54	3.85	4.90	5.92	13.38
Filing Date Shares Outstanding	97.39	71.03	67.38	45.09	39.43	36.7
Total Common Shares Outstanding	97.28	71.02	54.87	45.09	39.43	36.67
Working Capital	275.42	237.4	192.14	195.07	225.37	287.7
Book Value Per Share	4.18	3.42	4.08	4.93	6.92	7.90
Tangible Book Value	406.92	243.12	224.09	222.35	272.98	289.78
Tangible Book Value Per Share	4.18	3.42	4.08	4.93	6.92	7.90
Machinery	8.66	8.36	7.39	7.07	5.69	4.76
Leasehold Improvements	2.07	2.04	1.97	1.98	1.71	1.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q